E-Qure Corp. (EQUR)
E-Qure Corp. operates in the Medical - Devices industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, down 99.50% on the session, giving a market capitalisation of $6,909. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of 1.15 implies it has historically moved more than the broad market.
E-Qure Corp., a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery. The company was founded in 1988 and operates from its headquarters in New York, New York.
E-Qure Corp. is most often compared with the following Healthcare names: